Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination of alteplase and eptifibatide versus alteplase alone in acute ischemic stroke
IRCT20170117032025N9Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Apr 2021
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial in ischemic stroke comparing Alteplase alone with Alteplase plus eptifibatide (2 arms). Started Apr 2021; status: completed.
02
Drugs
tissue-plasminogen activatoreptifibatide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on IRCT20170117032025N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170117032025N9.